| 6th Nov 2026 3:00 pm |
RNS |
GSK publishes provisional dividend dates |
| 2nd Nov 2026 3:00 pm |
RNS |
Total Voting Rights |
| 28th Oct 2026 7:00 am |
RNS |
3rd Quarter Results |
| 26th Oct 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 26th Oct 2026 3:30 pm |
RNS |
Ris-Rez positive Ph 3 osteosarcoma data in China |
| 26th Oct 2026 7:05 am |
RNS |
Jemperli data show 76% complete response rate |
| 26th Oct 2026 7:00 am |
RNS |
Positive Mo-Rez Phase Ib data in ovarian cancer |
| 21st Oct 2026 7:00 am |
RNS |
US FDA approves Hibsago for chronic hepatitis B |
| 19th Oct 2026 5:21 pm |
RNS |
Jemperli approved in MSI-H/dMMR rectal cancer |
| 19th Oct 2026 7:00 am |
RNS |
Ris-Rez positive early data in lung cancer |
| 15th Oct 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 14th Oct 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 13th Oct 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 12th Oct 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 8th Oct 2026 3:00 pm |
RNS |
Wendy Becker CBE - New Directorship |
| 6th Oct 2026 3:00 pm |
RNS |
Admission to Trading |
| 1st Oct 2026 3:00 pm |
RNS |
Total Voting Rights |
| 24th Sep 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 22nd Sep 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 15th Sep 2026 7:00 am |
RNS |
GSK to acquire T cell-engager for multiple myeloma |
| 14th Sep 2026 7:00 am |
RNS |
Ris-Rez Positive Ph 3 OS Lung Cancer Data in China |
| 14th Sep 2026 7:00 am |
RNS |
Jideytro positive data for ROS1-positive NSCLC |
| 11th Sep 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 10th Sep 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 10th Sep 2026 7:00 am |
RNS |
Japan approval of Shingrix in a prefilled syringe |
| 9th Sep 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 9th Sep 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 1st Sep 2026 3:00 pm |
RNS |
Total Voting Rights |
| 1st Sep 2026 7:00 am |
RNS |
mRNA flu vaccine candidate to advance to phase III |
| 26th Aug 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 24th Aug 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 24th Aug 2026 7:02 am |
RNS |
First global approval for Hibsago in Japan |
| 24th Aug 2026 7:00 am |
RNS |
US FDA to review Jemperli for rectal cancer |
| 18th Aug 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 13th Aug 2026 3:33 pm |
RNS |
Director/PDMR Shareholding |
| 11th Aug 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 3rd Aug 2026 3:00 pm |
RNS |
Total Voting Rights |
| 30th Jul 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 28th Jul 2026 12:05 pm |
RNS |
New GSK flagship R&D centre in Cambridge |
| 28th Jul 2026 12:00 pm |
RNS |
2nd Quarter Results |
